Phio Pharmaceuticals Corp. (PHIO) Tops Q3 EPS by 260c

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q3 EPS of ($1.54), $2.60 better than the analyst estimate of ($4.14).

For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.

You May Also Be Interested In

• Jana Partners urges Cooper Companies to replace CEO and explore asset sales
• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Increasing unusual put option volume: AS DKS HBAN AQST RIG SATL MTZ HRL